ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+16.84%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$261M
AUM Growth
+$261M
Cap. Flow
+$14.5M
Cap. Flow %
5.55%
Top 10 Hldgs %
97.33%
Holding
16
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

1
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
$14.5M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$154M 59.18% 6,068,125 – –
VRNA
2
Verona Pharma
VRNA
$9.16B
$32.1M 12.29% 1,115,352 – –
SNDX icon
3
Syndax Pharmaceuticals
SNDX
$1.41B
$19.7M 7.56% 1,025,000 – –
BCAX
4
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
$14.5M 5.55% +568,919 New +$14.5M
BMEA icon
5
Biomea Fusion
BMEA
$116M
$8.07M 3.09% 798,757 – –
GLUE icon
6
Monte Rosa Therapeutics
GLUE
$296M
$7.8M 2.99% 1,472,331 – –
CMPS
7
Compass Pathways
CMPS
$424M
$6.08M 2.33% 964,500 – –
NUVB icon
8
Nuvation Bio
NUVB
$1.02B
$5.82M 2.23% 2,541,009 – –
PSTX
9
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$2.98M 1.14% 1,043,267 – –
TECX
10
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$2.55M 0.98% 84,148 – –
CALC icon
11
CalciMedica
CALC
$37.7M
$2.31M 0.88% 521,114 – –
ELEV
12
DELISTED
Elevation Oncology
ELEV
$1.7M 0.65% 2,834,910 – –
OKUR
13
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$1.51M 0.58% 886,075 – –
MRKR icon
14
Marker Therapeutics
MRKR
$12M
$886K 0.34% 314,286 – –
ACRS icon
15
Aclaris Therapeutics
ACRS
$209M
$500K 0.19% 434,455 – –
VIRX
16
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$66.4K 0.03% 288,571 – –